Work

p53 R248Q upregulation of VTCN1 via dual mechanisms as a driver of immune evasion and adaptive resistance to CDK4/6 inhibitors: Rationale for combination immunotherapy in endometrial cancer.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.5618

Authors: Yan Ding, Bilan Li

Institution: Tongji University

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162489770

Cites:

Cited by:

Related to: